{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:26:39Z","timestamp":1781915199329,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T00:00:00Z","timestamp":1408838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00101-014-2369-9","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T07:35:54Z","timestamp":1408692954000},"page":"775-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmakokinetik und Pharmakodynamik der Antibiotikatherapie","Pharmacokinetics and pharmacodynamics of antibiotic therapy"],"prefix":"10.1007","volume":"63","author":[{"given":"S.","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.","family":"Wicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kloft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Kees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,24]]},"reference":[{"key":"2369_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/510079","volume":"44","author":"Ambrose","year":"2007","unstructured":"Ambrose PG, Bhavnani SM, Rubino CM, Louie A et al (2007) Antimicrobial resistance: pharmacokinetics\u2010pharmacodynamics of antimicrobial therapy: it\u2019s not just for mice anymore. Clin Infect Dis 44(1):79\u201386","journal-title":"Clin Infect Dis"},{"key":"2369_CR2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0924-8579(02)00022-5","volume":"19","author":"Andes","year":"2002","unstructured":"Andes D, Craig WA (2002) Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents 19(4):261\u2013268","journal-title":"Int J Antimicrob Agents"},{"key":"2369_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","volume":"48","author":"Andrews","year":"2001","unstructured":"Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48(Suppl 1):5\u201316","journal-title":"J Antimicrob Chemother"},{"key":"2369_CR4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","volume":"312","author":"Barza","year":"1996","unstructured":"Barza M, Ioannidis JP, Cappelleri JC, Lau J (1996) Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 312(7027):338\u2013345","journal-title":"BMJ"},{"key":"2369_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40264-013-0031-0","volume":"36","author":"Boyer","year":"2013","unstructured":"Boyer A, Gruson D, Bouchet S, Clouzeau B et al (2013) Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. Drug Saf 36(4):217\u2013230","journal-title":"Drug Saf"},{"key":"2369_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/31.suppl_D.71","volume":"31","author":"Carbon","year":"1993","unstructured":"Carbon C (1993) Experimental endocarditis: a review of its relevance to human endocarditis. J Antimicrob Chemother 31(Suppl D):71\u201385","journal-title":"J Antimicrob Chemother"},{"key":"2369_CR7","first-page":"63","volume":"74","author":"Craig","year":"1990","unstructured":"Craig WA, Ebert SC (1990) Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis Suppl 74:63\u201370","journal-title":"Scand J Infect Dis Suppl"},{"key":"2369_CR8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","volume":"17","author":"Craig","year":"2003","unstructured":"Craig WA (2003) Basic pharmacodynamics of antibacterials with clinical applications to the use of \u03b2-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 17(3):479\u2013501","journal-title":"Infect Dis Clin North Am"},{"key":"2369_CR9","doi-asserted-by":"crossref","unstructured":"Craig WA (1995) Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 22(1\u20132):89\u201396","DOI":"10.1016\/0732-8893(95)00053-D"},{"key":"2369_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE, Gerding DN et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44(2):159\u2013177","journal-title":"Clin Infect Dis"},{"key":"2369_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","volume":"2","author":"Drusano","year":"2004","unstructured":"Drusano GL (2004) Antimicrobial pharmacodynamics: critical interactions of \u201ebug and drug\u201c. Nat Rev Microbiol 2(4):289\u2013300","journal-title":"Nat Rev Microbiol"},{"key":"2369_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM195303192481201","volume":"248","author":"Eagle","year":"1953","unstructured":"Eagle H, Fleischman R, Levy M (1953) \u201eContinuous\u201c vs. \u201ediscontinuous\u201c therapy with penicillin; the effect of the interval between injections on therapeutic efficacy. N Engl J Med 248(12):481\u2013488","journal-title":"N Engl J Med"},{"key":"2369_CR13","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1086\/647938","volume":"50","author":"Eisenstein","year":"2010","unstructured":"Eisenstein BI, Oleson FB Jr, Baltz RH (2010) Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis 50(Suppl 1):S10\u2013S15","journal-title":"Clin Infect Dis"},{"key":"2369_CR14","unstructured":"European Medicines Agency (2000) Points to consider on pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products. http:\/\/www.ema.europa.eu. Zugegriffen: 28 Nov. 2013"},{"key":"2369_CR15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","volume":"37","author":"Forrest","year":"1993","unstructured":"Forrest A, Nix DE, Ballow CH, Goss TF et al (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37(5):1073\u20131081","journal-title":"Antimicrob Agents Chemother"},{"key":"2369_CR16","first-page":"39","volume":"8","author":"Vossen","year":"2013","unstructured":"Vossen MG, Thalhammer F (2013) Effects of renal replacement therapy on antimicrobial therapy. Curr Clin Pharmacol 8(1):39\u201345","journal-title":"Curr Clin Pharmacol"},{"key":"2369_CR17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jac\/dkp434","volume":"65","author":"Gloede","year":"2010","unstructured":"Gloede J, Scheerans C, Derendorf H, Kloft C (2010) In vitro pharmacodynamic models to determine the effect of antibacterial drugs. J Antimicrob Chemother 65(2):186\u2013201","journal-title":"J Antimicrob Chemother"},{"key":"2369_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2110-5820-2-22","volume":"2","author":"Herendael","year":"2012","unstructured":"Herendael BV, Jeurissen A, Tulkens PM, Vlieghe E et al (2012) Continuous infusion of antibiotics in the critically ill: the new holy grail for beta-lactams and vancomycin? Ann Intensive Care 2(1):22","journal-title":"Ann Intensive Care"},{"key":"2369_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00133-06","volume":"52","author":"Kiem","year":"2008","unstructured":"Kiem S, Schentag JJ (2008) Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob Agents Chemother 52(1):24\u201336","journal-title":"Antimicrob Agents Chemother"},{"key":"2369_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","volume":"44","author":"Lodise","year":"2007","unstructured":"Lodise J, Lomaestro B, Drusano GL (2007) Piperacillin\u2010tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended\u2010infusion dosing strategy. Clin Infect Dis 44(3):357\u2013363","journal-title":"Clin Infect Dis"},{"key":"2369_CR21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2008.10.025","volume":"33","author":"Lorente","year":"2009","unstructured":"Lorente L, Jim\u00e9nez A, Mart\u00edn MM, Iribarren JL et al (2009) Clinical cure of ventilator-associated pneumonia treated with piperacillin\/tazobactam administered by continuous or intermittent infusion. Int J Antimicrob Agents 33(5):464\u2013468","journal-title":"Int J Antimicrob Agents"},{"key":"2369_CR22","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.clinthera.2007.11.003","volume":"29","author":"Lorente","year":"2007","unstructured":"Lorente L, Jim\u00e9nez A, Palmero S, Jim\u00e9nez JJ et al (2007) Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review. Clin Ther 29(11):2433\u20132439","journal-title":"Clin Ther"},{"key":"2369_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1345\/aph.1G467","volume":"40","author":"Lorente","year":"2006","unstructured":"Lorente L, Lorenzo L, Martin MM, Jimenez A et al (2006) Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann Pharmacother 40(2):219\u2013223","journal-title":"Ann Pharmacother"},{"key":"2369_CR24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dki079","volume":"55","author":"Mouton","year":"2005","unstructured":"Mouton JW, Dudley MN, Cars O, Derendorf H et al (2005) Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother 55(5):601\u2013607","journal-title":"J Antimicrob Chemother"},{"key":"2369_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","volume":"61","author":"Mouton","year":"2008","unstructured":"Mouton JW, Theuretzbacher U, Craig WA, Tulkens PM et al (2008) Tissue concentrations: do we ever learn? J Antimicrob Chemother 61(2):235\u2013237","journal-title":"J Antimicrob Chemother"},{"key":"2369_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2005.01.017","volume":"25","author":"Plock","year":"2005","unstructured":"Plock N, Kloft C (2005) Microdialysis \u2013 theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci 25(1):1\u201324","journal-title":"Eur J Pharm Sci"},{"key":"2369_CR27","unstructured":"Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW et al (2009) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis [Internet]. [cited 2014 May 11] http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1473309914700362"},{"key":"2369_CR28","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/CCM.0b013e3181a0054d","volume":"37","author":"Roberts","year":"2009","unstructured":"Roberts JA, Webb S, Paterson D, Ho KM et al (2009) A systematic review on clinical benefits of continuous administration of \u03b2-lactam antibiotics. Crit Care Med 37(6):2071\u20132078","journal-title":"Crit Care Med"},{"key":"2369_CR29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneurol.2011.141","volume":"7","author":"Udy","year":"2011","unstructured":"Udy AA, Roberts JA, Lipman J (2011) Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol 7(9):539\u2013543","journal-title":"Nat Rev Nephrol"},{"key":"2369_CR30","unstructured":"With K de, Allerberger F, Amann S et al; Deutsche Gesellschaft f\u00fcr Infektiologie e.\u00a0V. (2013) S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. http:\/\/www.awmf.org. Zugegriffen: 13 Aug. 2014"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-014-2369-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-014-2369-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-014-2369-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:56:12Z","timestamp":1558580172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-014-2369-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,24]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2369"],"URL":"https:\/\/doi.org\/10.1007\/s00101-014-2369-9","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,24]]}}}